Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 5
2005 3
2006 5
2007 1
2008 3
2009 4
2010 4
2011 4
2012 1
2013 3
2014 7
2015 8
2016 6
2017 8
2018 3
2019 5
2020 11
2021 11
2022 3
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Endovascular Treatment of Postpancreatectomy Hemorrhage from the Retroportal Artery with Compression of the Celiac Trunk by the Median Arcuate Ligament: A Case Report.
Kotera T, Tsurusaki M, Kozuki R, Urase A, Hirayama A, Ishii K. Kotera T, et al. Among authors: tsurusaki m. Interv Radiol (Higashimatsuyama). 2024 Mar 1;9(1):36-40. doi: 10.22575/interventionalradiology.2023-0002. eCollection 2024 Mar 1. Interv Radiol (Higashimatsuyama). 2024. PMID: 38524997 Free PMC article.
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma.
Aoki T, Kudo M, Ueshima K, Morita M, Chishina H, Takita M, Hagiwara S, Ida H, Minami Y, Tsurusaki M, Nishida N. Aoki T, et al. Among authors: tsurusaki m. Liver Cancer. 2023 May 11;13(1):56-69. doi: 10.1159/000531024. eCollection 2024 Feb. Liver Cancer. 2023. PMID: 38344443 Free PMC article.
A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma.
Iwamoto H, Suzuki H, Masuda A, Sakaue T, Nakamura T, Tanaka T, Sakai M, Imamura Y, Yano H, Torimura T, Koga H, Yasuda K, Tsurusaki M, Seki T, Kawaguchi T. Iwamoto H, et al. Among authors: tsurusaki m. iScience. 2024 Jan 4;27(2):108797. doi: 10.1016/j.isci.2024.108797. eCollection 2024 Feb 16. iScience. 2024. PMID: 38303694 Free PMC article.
Magnetic resonance imaging-based risk factors of hepatocellular carcinoma after direct-acting antiviral therapy: A multicenter observational study.
Ichikawa S, Motosugi U, Sawai Y, Ishida H, Imai Y, Kozaka K, Tsurusaki M, Sofue K, Murakami T, Kawai N, Matsuo M, Fukukura Y, Mawatari S, Shimizu T, Morisaka H, Inoue T, Goshima S. Ichikawa S, et al. Among authors: tsurusaki m. Hepatol Res. 2024 Jan;54(1):43-53. doi: 10.1111/hepr.13964. Epub 2023 Sep 19. Hepatol Res. 2024. PMID: 37676063
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma.
Tsujita Y, Sofue K, Ueshima E, Ueno Y, Hori M, Tsurusaki M, Murakami T. Tsujita Y, et al. Among authors: tsurusaki m. Magn Reson Med Sci. 2023 Apr 1;22(2):209-220. doi: 10.2463/mrms.rev.2022-0118. Epub 2023 Feb 16. Magn Reson Med Sci. 2023. PMID: 36792205 Free PMC article.
Comparison of Conventional Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnostic Accuracy of Staging in Patients with Intrahepatic Cholangiocarcinoma.
Nishioka E, Tsurusaki M, Kozuki R, Im SW, Kono A, Kitajima K, Murakami T, Ishii K. Nishioka E, et al. Among authors: tsurusaki m. Diagnostics (Basel). 2022 Nov 21;12(11):2889. doi: 10.3390/diagnostics12112889. Diagnostics (Basel). 2022. PMID: 36428949 Free PMC article.
90 results